Fintepla
Fintepla 360ML of 2.2MG/ML
What is Fintepla?
Fintepla (fenfluramine) is a prescription medication approved for the treatment of seizures associated with Dravet syndrome in patients two years of age and older. It works by reducing the frequency of convulsive seizures when added to other seizure medications, but its exact mechanism of action in treating seizures is not fully understood. Fintepla is classified as a Schedule IV controlled substance due to its similarity to the appetite suppressant fenfluramine, which was withdrawn from the market due to safety concerns.
Side Effects
- Decreased appetite
- Drowsiness
- Diarrhea
Warnings
- Risk of QT Prolongation and ventricular arrhythmia
- Increased risk of suicidal behavior and ideation
- Potential for somnolence or sedation which can impair the ability to perform tasks
- Possible interaction with other central nervous system depressants
See your results below for :
Fintepla 360ML of 2.2MG/ML
:
Bottle - 1
Fintepla Coupons & Prices
What is Fintepla ?
Fintepla (fenfluramine) is a prescription medication approved for the treatment of seizures associated with Dravet syndrome in patients two years of age and older. It works by reducing the frequency of convulsive seizures when added to other seizure medications, but its exact mechanism of action in treating seizures is not fully understood. Fintepla is classified as a Schedule IV controlled substance due to its similarity to the appetite suppressant fenfluramine, which was withdrawn from the market due to safety concerns.
Need a Prescription or Refill?
Affordable, same-day video appointments for prescriptions or refills from licensed healthcare providers on your schedule. HSA & FSA-eligible.
Same-day video visit. Sent to your pharmacy.
- Decreased appetite
- Drowsiness
- Diarrhea
- Fatigue
- Fever
- Weight decrease
- Risk of QT Prolongation and ventricular arrhythmia
- Increased risk of suicidal behavior and ideation
- Potential for somnolence or sedation which can impair the ability to perform tasks
- Possible interaction with other central nervous system depressants